What Factors Associate With Symptom Recurrence After Anti-reflux Surgery for GERD?
The most reliable factors associated with symptom recurrence after anti-reflux surgery for patients with gastroesophageal reflux disease (GERD) are a primary complaint of extraesophageal reflux symptoms and lack preoperative response to acid-suppression therapy, researchers report in the May issue of Clinical Gastroenterology and Hepatology.
Approximately 10% of the US population has daily symptoms of GERD. Anti-reflux surgery reduces symptoms on more than 90% of patients with typical reflux (heartburn, regurgitation). It is an option for patients whose symptoms are not controlled with lifestyle modification or acid-suppression therapy, or when complications develop.
Guidelines state that anti-reflux surgery should be considered for patients with typical esophageal reflux symptoms who are responsive to, but intolerant of, proton pump inhibitor (PPI) therapy; typical reflux symptoms considered troublesome (especially regurgitation) despite PPI therapy; typical reflux symptoms who prefer a more definitive option; or extra-esophageal symptoms when reflux etiology has been established.
However, it is difficult to predict the response to anti-reflux surgery for patients with extra-esophageal symptoms (cough, asthma/wheezing, hoarseness, or throat clearing).
Time to primary symptom recurrence by primary symptom and preoperative response to acid-suppressive therapy. Hb, heartburn; reg, regurgitation; extra, extraesophageal
Symptom recurrence after anti-reflux surgery was associated with having primarily extraesophageal symptoms (adjusted hazard ratio, 2.34) and poor preoperative response to acid-suppression therapy (hazard ratio, 3.85).
Patients with primary extra-esophageal symptoms who had a full or partial preoperative response to acid-suppressive therapy were less likely to have symptom recurrence than patients with poor response to acid-suppressive therapy. Severity of acid reflux on pH testing, symptom indices, severity of esophagitis, and hiatal hernia size were not associated with symptom response.
Limitations of the study include its retrospective design, single-center cohort, and somewhat homogenous patient population (predominantly Caucasian and obese). A multi-center prospective study of a diverse study population, using a standardized assessment tool, is needed to fully determine the utility of the variables discussed in this study.
Dr. Kristine Novak has worked as an editor at biomedical research journals and as a science writer for over 15 years, covering advances in gastroenterology, hepatology, cancer, immunology, biotechnology, molecular genetics, and clinical trials. She has a PhD in cell biology and an interest in all areas of medical research.
